PERSPECTIVE THERAPEUTICS, INC.: 10-Q filed 2014-11-14

Name: PERSPECTIVE THERAPEUTICS, INC.: 10-Q filed 2014-11-14
Creator: PERSPECTIVE THERAPEUTICS, INC.

What PERSPECTIVE THERAPEUTICS, INC. reported in its quarterly report filed 2014-11-14 (fiscal Q1 2015): 27 published measures, 56 facts as tagged in accession 0001144204-14-068739.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-11-14
Fiscal period: fiscal Q1 2015
Accession: 0001144204-14-068739 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-09-30	25,539,315	USD
At 2014-06-30	26,549,255	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-09-30	2,115,270	USD
At 2014-06-30	2,593,487	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-09-30	23,424,045	USD
At 2014-06-30	23,955,768	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-09-30	2,075,317	USD
At 2014-06-30	7,680,073	USD
At 2013-09-30	5,284,163	USD
At 2013-06-30	2,899,927	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-785,862	USD	92
2013-07-01 to 2013-09-30	-1,270,906	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	7,453	USD	92
2013-07-01 to 2013-09-30	2,041	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-09-30	-58,836,318	USD
At 2014-06-30	-58,050,456	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-09-30	855,398	USD
At 2014-06-30	1,017,915	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	21,453	USD	92
2013-07-01 to 2013-09-30	38,353	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-1,161,106	USD	92
2013-07-01 to 2013-09-30	-1,234,519	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-09-30	13,727,763	USD
At 2014-06-30	19,214,900	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	3,451	USD	92
2013-07-01 to 2013-09-30	741	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-09-30	979,066	USD
At 2014-06-30	1,153,927	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-09-30	962,259	USD
At 2014-06-30	913,049	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	1,106,304	USD	92
2013-07-01 to 2013-09-30	1,157,211	USD	92

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2014-09-30	407,479	USD
At 2014-06-30	359,737	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-54,802	USD	92
2013-07-01 to 2013-09-30	-77,308	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	176,610	USD	92
2013-07-01 to 2013-09-30	146,990	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-09-30	54,883,445	shares
At 2014-06-30	54,701,708	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-09-30	82,213,811	USD
At 2014-06-30	81,959,853	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-09-30	258,638	USD
At 2014-06-30	264,076	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2014-09-30	252,183	USD
At 2014-06-30	206,047	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-788,520	USD	92
2013-07-01 to 2013-09-30	-1,999,942	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	575,951	USD	92
2013-07-01 to 2013-09-30	651,036	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	375,244	USD	92
2013-07-01 to 2013-09-30	-36,387	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	37,889	USD	92
2013-07-01 to 2013-09-30	33,475	USD	92

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	47,742	USD	92
2013-07-01 to 2013-09-30	30,673	USD	92

Inspect the source

Entity: PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
Captured: 2026-09-19T15:00:29.793Z
SEC response SHA-256: 80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))